The Niche Podcast

Join Dr. Noah Goodson every Monday for a summary of top news in the biotech, clinical research, and life science industries.

Monthly bonus episodes are interviews with industry experts and luminaries across the biotech, pharmaceuticals, life science, and clinical research space.

The Niche Episode 062 – Allergan + AbbVie, CHOP, Amgen + TeneoBio, Cidara, Viatris + Biocon, SOPHiA, Caribou, Artois

This week, look closer – with drops, controlled gene therapy, acquisitions in antibodies, new antifungals, new biosimilars, and several IPOs

Find out more at
https://thenichepod.com

Story References
https://tinyurl.com/Niche-061-1
https://tinyurl.com/Niche-061-2
https://tinyurl.com/Niche-061-3
https://tinyurl.com/Niche-061-4
https://tinyurl.com/Niche-061-5
https://tinyurl.com/Niche-061-6
https://tinyurl.com/Niche-061-7
https://tinyurl.com/Niche-061-8

Music by Luke Goodson
https://www.soundcloud.com/lukegoodson

About the Show
The Niche Podcast brings you interviews with industry experts and top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.

 

The Niche Episode 061 – Bonus Episode – Interview with Brazen Bio founders Shawn Carbonell and Brent Witgen

In this special bonus episode, Dr. Noah Goodson sits down with biotech founders Dr. Shawn Carbonell and Dr. Brent Witgen to discuss their new founder-friendly biotech incubator Brazen Bio.

Find out more at
https://thenichepod.com

Story References
https://wefunder.com/brazenbio/
https://www.linkedin.com/company/brazenbio/
https://www.brazen.bio

Music by Luke Goodson
https://www.soundcloud.com/lukegoodson

The Niche Podcast brings you interviews with industry experts and top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.

 

The Niche Episode 060 – PacBio + Omniome, Eli Lilly, Adverum, Seres, Pfizer + Arvinas

Sequencing technology, decentralized Alzheimer’s trials, busts in gene therapy and microbiomes, and a $2.4B oncology collaboration

 Find out more at
https://thenichepod.com

Story References
https://tinyurl.com/Niche-060-1
https://tinyurl.com/Niche-060-2
https://tinyurl.com/Niche-060-3
https://tinyurl.com/Niche-060-4
https://tinyurl.com/Niche-060-5

Music by Luke Goodson
https://www.soundcloud.com/lukegoodson

The Niche Podcast brings you interviews with industry experts and top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.

 

The Niche Episode 059 – IRLAB + IPSEN, Merck (MSD), Pfizer, Regeneron, GSK, Erasca

Dopamine deals, Merck vaccine approval, Epipen settlements, billions in buildings, and outsized Oncology IPO.

Story References
https://tinyurl.com/Niche-059-1
https://tinyurl.com/Niche-059-2
https://tinyurl.com/Niche-059-3
https://tinyurl.com/Niche-059-4
https://tinyurl.com/Niche-059-5
https://tinyurl.com/Niche-059-6
https://tinyurl.com/Niche-059-7

Music by Luke Goodson
https://www.soundcloud.com/lukegoodson

The Niche Podcast brings you interviews with industry experts and top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.

The Niche Episode 058¬ – BGI Group, Genebass, Astellas, Seagen, Parexel, Hyperfine SPAC

Muddy waters of data privacy and genetic databases, antibody-drug conjugate approvals, unabetted wild enthusiasm for CROs, and mobile MRIs go public.

Story References
https://tinyurl.com/Niche-058-1
https://tinyurl.com/Niche-058-2
https://tinyurl.com/Niche-058-3
https://tinyurl.com/Niche-058-4
https://tinyurl.com/Niche-058-5

Music by Luke Goodson
https://www.soundcloud.com/lukegoodson


About The Niche Podcast

The Niche Podcast brings you interviews with industry experts and top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.

The Niche Episode 057 – Bonus Interview with Dr. Jayne Morgan, Executive Director COVID19 Task Force

Welcome to a special bonus episode as we kick off Season 2 the Niche Podcast. I sat down with Dr. Jayne Morgan, the head of the COVID19 task force at Piedmont Healthcare to talk about her career in clinical research. 

Sponsors
https://www.thescopemethod.com

Dr. Morgan on LinkedIn
https://tinyurl.com/Niche-057-1

Dr. Morgan on Instagram
https://tinyurl.com/Niche-057-2

Music by Luke Goodson
https://www.soundcloud.com/lukegoodson

About The Niche Podcast

The Niche Podcast brings you interviews with industry experts and top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.

About Instructor

If you'd like to comment on this course or lecture please Register or Login.

THIS CONTENT IS FOR

Registered Users

Please login or register to continue.